{"organizations": [], "uuid": "096b26f77c3ae385665886dcbe79e32ca035bf62", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-corbus-pharmaceuticals-reports-201/brief-corbus-pharmaceuticals-reports-2017-financial-results-and-provides-clinical-update-idUSASC09RQE", "country": "US", "domain_rank": 408, "title": "BRIEF-Corbus Pharmaceuticals Reports 2017 Financial Results And Provides Clinical Update", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-12T13:13:00.000+02:00", "replies_count": 0, "uuid": "096b26f77c3ae385665886dcbe79e32ca035bf62"}, "author": "", "url": "https://www.reuters.com/article/brief-corbus-pharmaceuticals-reports-201/brief-corbus-pharmaceuticals-reports-2017-financial-results-and-provides-clinical-update-idUSASC09RQE", "ord_in_thread": 0, "title": "BRIEF-Corbus Pharmaceuticals Reports 2017 Financial Results And Provides Clinical Update", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "corbus pharmaceuticals holdings inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 12, 2018 / 11:15 AM / Updated 9 minutes ago BRIEF-Corbus Pharmaceuticals Reports 2017 Financial Results And Provides Clinical Update Reuters Staff March 12 (Reuters) - Corbus Pharmaceuticals Holdings Inc : * CORBUS PHARMACEUTICALS REPORTS 2017 FINANCIAL RESULTS AND PROVIDES CLINICAL UPDATE * CORBUS PHARMACEUTICALS HOLDINGS INC - CASH AND CASH EQUIVALENTS BALANCE AT DECEMBER 31, 2017 WAS APPROXIMATELY $62.5 MILLION * CORBUS PHARMACEUTICALS - EXPECTS CURRENT CASH ON HAND, EXPECTED MILESTONE PAYMENTS TO FUND OPERATIONS THROUGH Q4 OF 2019 Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-12T13:13:00.000+02:00", "crawled": "2018-03-12T13:35:21.005+02:00", "highlightTitle": ""}